The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Thomas Dolca since 2019.
This trader's CIK number is 1768239.
At the time of last reporting, Thomas Dolca was the Director of Chinook Therapeutics, Inc.. (stock ticker symbol KDNY).
Also see all insider trading activities at Chinook Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | KDNY | 0 | $0 | 0 | $0 | 3,300 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | PRNB | 0 | $0 | 30,000 | $2,701,065 | 30,000 | $713,100 |
| 2019 | PRNB | 0 | $0 | 495 | $29,700 | 0 | $0 |
1. Chinook Therapeutics, Inc. (KDNY)
2. Principia Biopharma Inc. (PRNB)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-05-26 | KDNY | Option Ex | 3,300 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-08-18 | PRNB | Sale | 15,000 | 100.00 | 1,500,000 |
| 2020-08-18 | PRNB | Option Ex | 15,000 | 23.77 | 356,550 |
| 2020-07-15 | PRNB | Sale | 15,000 | 80.07 | 1,201,065 |
| 2020-07-15 | PRNB | Option Ex | 15,000 | 23.77 | 356,550 |
| 2019-12-19 | PRNB | Sale | 495 | 60.00 | 29,700 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Thomas Dolca (Director of Chinook Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.